High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
| Autor: | Zeimet, AG, Widschwendter, M, Uhl-Steidl, M, Müller-Holzner, E, Daxenbichler, G, Marth, C, Dapunt, O, Zeimet, A G, Müller-Holzner, E |
|---|---|
| Zdroj: | British Journal of Cancer; Dec1997, Vol. 76 Issue 12, p1646-1651, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|